Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.44 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | RELA | Q04206 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18353270 | 0.92 | RELA (0.50) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL12292310 | 0.92 | RELA (0.50) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL14491181 | 0.88 | RELA (0.46) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL13679125 | 0.88 | PTGS1 (0.50) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL25622462 | 0.86 | TRPM8 (0.48) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL14196508 | 0.86 | RELA (0.44) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL13380679 | 0.86 | PTGS1 (0.45) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL15223124 | 0.86 | PTGS1 (0.41) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL23918549 | 0.86 | TYR (0.64) | PTGS1PTGS2KDM4ETYRMAPK1 | |
| SCHEMBL12922764 | 0.86 | TYR (0.44) | PTGS1KDM4ETYRMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| EP-2423179-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | AOC2, AOC3, H1-4 | PTGS1 3501/4885PTGS2 3422/4885KDM4E 1332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.